Two new draft monographs available for public consultation on Pharmeuropa  EDSForm

All stakeholders are invited to submit their comments on the new draft monographs on:

-    Quetiapine, 50, 100 mg and 150 mg, capsules (F1008),

and
-    Sulfamethoxazole/trimethoprim 40 mg/mL + 8 mg/mL, oral suspension (F1004),

published in Issue 2 of the Pharmeuropa EDSForm consultation platform.

Further information on the EDSForm, the work of the EDSForm Working Party and the EDQM’s concerted response to drug shortages can be found here (link).

The closing date for comments is 30 September 2026.

Users can register for free access to the Pharmeuropa EDSForm platform. 

For more information on how to create your account or how to use the website, please consult the User manual.